doi:10.3969/j.issn.1673-8640.2020.03.017

Abstract

CLC Number:

R446.1

Figures/Tables 4

References 10

[1]	王炳予,袁星星,刘长发,等. 解毒化瘀汤治疗活动期溃疡性结肠炎的临床疗效及其对血清细胞因子和凝血指标的影响[J]. 上海中医药大学学报,2017,31(4):32-37.
[2]	胡妍妍,沈永华,于成功,等. 凝血功能检测对评估溃疡性结肠炎患者血液高凝状态的价值[J]. 江苏医药,2017,43(11):765-769.
[3]	中华医学会消化病学分会炎症性肠病学组. 炎症性肠病诊断与治疗的共识意见(2012年·广州)[J]. 胃肠病学,2012,17(12):763-781.
[4]	杨剑,陈学清. 同型半胱氨酸、D-二聚体在溃疡性结肠炎中的早期诊断价值[J]. 热带医学杂志,2016,16(4):448-451.
[5]	强薇,魏秀芹. 活动期溃疡性结肠炎患者凝血指标变化及其临床指导价值[J]. 现代仪器与医疗,2017,23(6):65-67.
[6]	王大秀,韩继武. 血小板、纤维蛋白原、D-二聚体与溃疡性结肠炎相关性的研究[J]. 胃肠病学,2018,23(8):486-488.
[7]	于佳弘,于雪娇,杜晓雪,等. D-D、FIB、PLT等凝血功能指标与肺癌患者外周血CTC及病理特征的相关性研究[J]. 肿瘤药学,2017,7(5):596-599.
[8]	赵月清,张瑞军. D-二聚体的检测在临床中的应用[J]. 疾病监测与控制,2017,11(2):120-122.
[9]	钱佶,董时洁,陈国昌. 溃疡性结肠炎患者血小板计数、血小板平均体积和D-二聚体检测的临床意义[J]. 南通大学学报(医学版),2016,36(1):72-74.
[10]	董肖肖,张鸣鸣,姜大磊,等. 血小板活化在溃疡性结肠炎发病中的作用[J]. 胃肠病学和肝病学杂志,2015,24(9):1088-1090.

组别	例数	Fib/（g/L）	DD/（μg/mL）	PLT/（×10⁹/L）
缓解期组	31	2.73±0.66^*	0.57±0.13^*	242.61±63.75^*
活动期组	52	3.35±0.81^*#	0.94±0.25^*#	267.44±81.33^*#
对照组	40	1.95±0.37	0.24±0.05	221.25±57.62
F值		99.178	166.369	16.797
P值		<0.001	<0.001	<0.001

组别	例数	Fib/（g/L）	DD/（μg/mL）	PLT/（×10⁹/L）
缓解期组	31	2.73±0.66^*	0.57±0.13^*	242.61±63.75^*
活动期组	52	3.35±0.81^*#	0.94±0.25^*#	267.44±81.33^*#
对照组	40	1.95±0.37	0.24±0.05	221.25±57.62
F值		99.178	166.369	16.797
P值		<0.001	<0.001	<0.001

组别	例数	Fib/（g/L）	DD/（μg/mL）	PLT/（×10⁹/L）
轻度组	27	2.67±0.85	0.77±0.23	251.78±62.44
中度组	16	3.69±1.17^*	1.39±0.35^*	317.69±72.38^*
重度组	9	4.83±1.26^*#	2.48±0.41^*#	357.43±84.19^*
F值		13.674	96.530	12.737
P值		<0.001	<0.001	<0.001

组别	例数	Fib/（g/L）	DD/（μg/mL）	PLT/（×10⁹/L）
轻度组	27	2.67±0.85	0.77±0.23	251.78±62.44
中度组	16	3.69±1.17^*	1.39±0.35^*	317.69±72.38^*
重度组	9	4.83±1.26^*#	2.48±0.41^*#	357.43±84.19^*
F值		13.674	96.530	12.737
P值		<0.001	<0.001	<0.001

[1]	FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114.
[2]	SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120.
[3]	LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129.
[4]	YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140.
[5]	XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146.
[6]	CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152.
[7]	. [J]. Laboratory Medicine, 2023, 38(12): 1153-1156.
[8]	. [J]. Laboratory Medicine, 2023, 38(12): 1157-1159.
[9]	WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166.
[10]	YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172.
[11]	DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176.
[12]	GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182.
[13]	. [J]. Laboratory Medicine, 2023, 38(12): 1183-1185.
[14]	. [J]. Laboratory Medicine, 2023, 38(12): 1186-1190.
[15]	. [J]. Laboratory Medicine, 2023, 38(12): 1191-1194.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 4

References 10

Related Articles 15

Recommended Articles

Metrics